AAAAAA
Results: 1-25/38
Authors:
BABAZONO A
WEINER J
TSUDA T
MINO Y
HILLMAN AL
Citation: A. Babazono et al., THE EFFECT OF A REDISTRIBUTION SYSTEM FOR HEALTH-CARE FOR THE ELDERLYON THE FINANCIAL PERFORMANCE OF HEALTH-INSURANCE SOCIETIES IN JAPAN, International journal of technology assessment in health care, 14(3), 1998, pp. 458-466
Authors:
HILLMAN AL
Citation: Al. Hillman, MEDIATORS OF PATIENT TRUST, JAMA, the journal of the American Medical Association, 280(19), 1998, pp. 1703-1704
Authors:
ROTHENBERG R
KOPLAN JP
CUTLER C
HILLMAN AL
Citation: R. Rothenberg et al., CHANGING PEDIATRIC PRACTICE IN A CHANGING MEDICAL ENVIRONMENT - FACTORS THAT INFLUENCE WHAT PHYSICIANS DO, Pediatric annals, 27(4), 1998, pp. 241-250
Authors:
HILLMAN AL
RIPLEY K
GOLDFARB N
NUAMAH I
WEINER J
LUSK E
Citation: Al. Hillman et al., PHYSICIAN FINANCIAL INCENTIVES AND FEEDBACK - FAILURE TO INCREASE CANCER SCREENING IN MEDICAID MANAGED CARE, American journal of public health, 88(11), 1998, pp. 1699-1701
Authors:
HILLMAN AL
Citation: Al. Hillman, POLITICAL-ECONOMY AND POLITICAL CORRECTNESS, Public choice, 96(3-4), 1998, pp. 219-239
Authors:
HILLMAN AL
Citation: Al. Hillman, COMMENTARY - BURDEN OF PROOF IN AN ERA OF OUTCOMES RESEARCH AND MANAGED CARE, Health services research, 33(1), 1998, pp. 75-78
Authors:
GRANATA AV
HILLMAN AL
Citation: Av. Granata et Al. Hillman, COMPETING PRACTICE GUIDELINES - USING COST-EFFECTIVENESS ANALYSIS TO MAKE OPTIMAL DECISIONS, Annals of internal medicine, 128(1), 1998, pp. 56-63
Authors:
YEE GC
HILLMAN AL
Citation: Gc. Yee et Al. Hillman, APPLIED PHARMACOECONOMICS - WHEN CAN PUBLICATION BE LEGITIMATELY WITHHELD, PharmacoEconomics, 12(5), 1997, pp. 511-516
Authors:
LUCE BR
HILLMAN AL
Citation: Br. Luce et Al. Hillman, WHEN IS A COST-EFFECTIVENESS CLAIM VALID - HOW MUCH SHOULD THE FDA CARE, American journal of managed care, 3(11), 1997, pp. 1660-1666
Authors:
HILLMAN AL
Citation: Al. Hillman, QUANTITATIVE RESEARCH TO DEMONSTRATE THE ADVANTAGES OF COLLABORATIVE PRACTICE, Women's health issues, 7(5), 1997, pp. 310-312
Authors:
RAMSEY SD
HILLMAN AL
PAULY MV
Citation: Sd. Ramsey et al., THE EFFECTS OF HEALTH-INSURANCE ON ACCESS TO NEW MEDICAL TECHNOLOGIES, International journal of technology assessment in health care, 13(2), 1997, pp. 357-367
Authors:
BARTLETT JG
ANDRIOLE VT
ARNO P
BROWN RB
ETCHASON J
FILE TM
HADLOCK C
HILLMAN AL
NIEDERMAN MS
RUSH D
SCHWARTZ S
STELMACH WJ
TICE AD
Citation: Jg. Bartlett et al., CONSENSUS ON EARLY INTERVENTION IN COMMUNITY-ACQUIRED PNEUMONIA - PANEL DISCUSSION, Infectious diseases in clinical practice, 5, 1996, pp. 174-178
Authors:
BARTLETT JG
HILLMAN AL
NIEDERMAN MS
SCHWARTZ S
Citation: Jg. Bartlett et al., CLINICAL AND ECONOMIC CONSENSUS ON EARLY INTERVENTION IN COMMUNITY-ACQUIRED PNEUMONIA, Infectious diseases in clinical practice, 5, 1996, pp. 179-184
Authors:
HILLMAN AL
BRENNER MK
CAPLAN AL
CAREY J
CHAMPEY Y
CULVER KW
DRUMMOND MF
FREUND DA
HOLMES EW
KELLEY WN
KOLATA G
LEVINE MN
LEVY E
SCHONDELMEYER SW
VELU T
WILSON JM
Citation: Al. Hillman et al., GENE-THERAPY - SOCIOECONOMIC AND ETHICAL ISSUES A ROUND-TABLE DISCUSSION, Human gene therapy, 7(9), 1996, pp. 1139-1144
Authors:
HILLMAN AL
SCHWARTZ JS
WILLIAN MK
PESKIN E
ROEHRBORN CG
OESTERLING JE
MASON MF
MAURATH CJ
DEVERKA PA
PADLEY RJ
Citation: Al. Hillman et al., THE COST-EFFECTIVENESS OF TERAZOSIN AND PLACEBO IN THE TREATMENT OF MODERATE TO SEVERE BENIGN PROSTATIC HYPERPLASIA, Urology, 47(2), 1996, pp. 169-178
Authors:
HILLMAN AL
Citation: Al. Hillman, SUMMARY OF ECONOMIC-ANALYSIS OF HEALTH-CARE TECHNOLOGY - A REPORT ON PRINCIPLES, Medical care, 34(12), 1996, pp. 193-196
Authors:
HILLMAN AL
URSPRUNG HW
Citation: Al. Hillman et Hw. Ursprung, THE POLITICAL-ECONOMY OF TRADE LIBERALIZATION IN THE TRANSITION, European economic review, 40(3-5), 1996, pp. 783-794
Authors:
HILLMAN AL
PAULY MV
SCHWARTZ JS
Citation: Al. Hillman et al., PRINCIPLES OF ECONOMIC-ANALYSIS OF HEALTH-CARE TECHNOLOGY, Annals of internal medicine, 125(2), 1996, pp. 157-157
Authors:
BLOOM BS
HILLMAN AL
LAMONT B
LISS C
SCHWARTZ JS
STEVER GJ
Citation: Bs. Bloom et al., OMEPRAZOLE OR RANITIDINE PLUS METOCLOPRAMIDE FOR PATIENTS WITH SEVEREEROSIVE ESOPHAGITIS - A COST-EFFECTIVENESS ANALYSIS, PharmacoEconomics, 8(4), 1995, pp. 343-349
Authors:
HILLMAN AL
KIM MS
Citation: Al. Hillman et Ms. Kim, ECONOMIC DECISION-MAKING IN HEALTH-CARE - A STANDARD APPROACH TO DISCOUNTING HEALTH OUTCOMES, PharmacoEconomics, 7(3), 1995, pp. 198-205
Authors:
HILLMAN AL
Citation: Al. Hillman, THE IMPACT OF PHYSICIAN FINANCIAL INCENTIVES ON HIGH-RISK POPULATIONSIN MANAGED CARE, Journal of acquired immune deficiency syndromes and human retrovirology, 8, 1995, pp. 23-30
Authors:
HILLMAN AL
Citation: Al. Hillman, COST-EFFECTIVENESS - FROM WHOSE PERSPECTIVE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 14-18
Authors:
HILLMAN AL
GOLDFARB N
Citation: Al. Hillman et N. Goldfarb, EXEMPLARY QUALITY IMPROVEMENT PROGRAMS IN HMOS, The Joint Commission journal on quality improvement, 21(9), 1995, pp. 457-464
Authors:
BABAZONO A
HILLMAN AL
Citation: A. Babazono et Al. Hillman, DECLINING COST-EFFECTIVENESS OF SCREENING FOR DISEASE - THE CASE OF GASTRIC-CANCER IN JAPAN, International journal of technology assessment in health care, 11(2), 1995, pp. 354-364
Authors:
LOWE FC
MCDANIEL RL
CHMIEL JJ
HILLMAN AL
Citation: Fc. Lowe et al., ECONOMIC MODELING TO ASSESS THE COSTS OF TREATMENT WITH FINASTERIDE, TERAZOSIN, AND TRANSURETHRAL RESECTION OF THE PROSTATE FOR MEN WITH MODERATE TO SEVERE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA, Urology, 46(4), 1995, pp. 477-483